Travere Therapeutics
TVTX
TVTX
120 hedge funds and large institutions have $845M invested in Travere Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5.52% less ownership
Funds ownership: 107.54% → 102.02% (-5.5%)
18% less capital invested
Capital invested by funds: $1.03B → $845M (-$183M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
120
Holding in Top 10
4
Calls
$16.1M
Puts
$1.45M
Top Buyers
| 1 | +$8.26M | |
| 2 | +$2.93M | |
| 3 | +$2.86M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.63M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.12M | |
| 3 | -$5.22M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.33M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$3.35M |